ArticleCureus2025
Ketosis-Prone Diabetes in Severe Hypertriglyceridemia-Induced Pancreatitis: A Case Report.
Article in Cureus, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Diabetic ketoacidosis (DKA) is a serious acute complication commonly associated with type 1 diabetes mellitus (T1DM). It is characterized by elevated blood glucose levels, increased ketone production due to insufficient insulin, and metabolic acidosis. Acute pancreatitis (AP) is an inflammatory condition of the pancreas that can range from mild, self-limiting episodes to severe, life-threatening illness. The triad of DKA, hypertriglyceridemia, and AP presents a unique and challenging clinical scenario. This report describes the case of a 41-year-old female diagnosed with ketosis-prone diabetes and severe hypertriglyceridemia-induced pancreatitis. The case highlights several important considerations for clinicians and underscores the intricate interplay between metabolic disturbances, emphasizing the need for a comprehensive, multidisciplinary approach to management and treatment to address underlying causes and prevent future complications.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.